- Home
- PLBY vs CALC Comparison
PLBY vs CALC Comparison
Compare PLBY & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLBY
- CALC
- Stock Information
- Founded
- PLBY 1953
- CALC 2011
- Country
- PLBY United States
- CALC United States
- Employees
- PLBY N/A
- CALC N/A
- Industry
- PLBY Recreational Games/Products/Toys
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- PLBY Consumer Discretionary
- CALC Health Care
- Exchange
- PLBY Nasdaq
- CALC Nasdaq
- Market Cap
- PLBY 53.2M
- CALC 44.7M
- IPO Year
- PLBY N/A
- CALC N/A
- Fundamental
- Price
- PLBY $0.72
- CALC $4.36
- Analyst Decision
- PLBY Buy
- CALC Strong Buy
- Analyst Count
- PLBY 2
- CALC 4
- Target Price
- PLBY $2.35
- CALC $20.50
- AVG Volume (30 Days)
- PLBY 258.3K
- CALC 39.7K
- Earning Date
- PLBY 11-07-2024
- CALC 11-07-2024
- Dividend Yield
- PLBY N/A
- CALC N/A
- EPS Growth
- PLBY N/A
- CALC N/A
- EPS
- PLBY N/A
- CALC N/A
- Revenue
- PLBY $125,850,000.00
- CALC N/A
- Revenue This Year
- PLBY N/A
- CALC N/A
- Revenue Next Year
- PLBY N/A
- CALC N/A
- P/E Ratio
- PLBY N/A
- CALC N/A
- Revenue Growth
- PLBY N/A
- CALC N/A
- 52 Week Low
- PLBY $0.43
- CALC $1.75
- 52 Week High
- PLBY $1.55
- CALC $8.38
- Technical
- Relative Strength Index (RSI)
- PLBY 53.39
- CALC 49.19
- Support Level
- PLBY $0.66
- CALC $4.05
- Resistance Level
- PLBY $0.77
- CALC $4.58
- Average True Range (ATR)
- PLBY 0.06
- CALC 0.38
- MACD
- PLBY -0.00
- CALC -0.01
- Stochastic Oscillator
- PLBY 41.43
- CALC 47.43
About PLBY PLBY Group Inc.
PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need. Its proprietary technology targets the inhibition of calcium release-activated calcium channels designed to modulate the immune response and protect against tissue cell injury, with the potential to provide therapeutic benefits in life-threatening inflammatory diseases for which there are no approved therapies.